Date Range
toReport Types
Condition
See all (10)
Region of the Body
See all (8)
Specialties
See all (18)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Alendronate is superior to alfacalcidol in preventing glucocorticoid-induced bone loss
N Engl J Med. 2006 Aug 17;355(7):675-84
Discontinuing alendronate after 5 years of treatment, does it affect fracture risk?
JAMA. 2006 Dec 27;296(24):2927-38.
Alendronate treatment for fibrous dysplasia, a rare skeletal disorder
J Clin Endocrinol Metab. 2014 Nov;99(11):4133-40.
Effectiveness of Alendronate versus Alfacalcidol in maintaining bone mineral density
Journal of Bone and Joint Surgery American; 2011; 93(A); 1203-1209
Denosumab increases bone mass but does not reduce fracture risk compared to alendronate
Int J Clin Pract. 2012 Apr;66(4):399-408. doi: 10.1111/j.1742-1241.2011.02806.x. Epub 2012 Feb 7
Alendronate & zoledronate both reduce hip and vertebral fracture risk compared to placebo
Gynecol Endocrinol. 2013 Dec;29(12):1005-14. doi: 10.3109/09513590.2013.813468. Epub 2013 Sep 25
Combined parathyroid hormone+alendronate therapy versus PTH monotherpy for osteoporosis
J Invest Surg. 2015 Dec;28(6):309-16
Bisphosphonates in revision THA ineffective in altering pseudomembrane cytokine expression
J Arthroplasty. 2010 Sep;25(6):958-63
The role of alendronate in osteoporosis patients undergoing PLIF
J Neurosurg Spine. 2011 Apr;14(4):500-7. doi: 10.3171/2010.11.SPINE10245. Epub 2011 Jan 28
The effect of alendronate post-TKA on bone mineral density and clinical outcome
Bone Joint J. 2015 Mar;97-B(3):337-45
Alendronate is an effective way of increasing BMD and reducing bone turnover
J Int Med Res. 2011;39(1):302-10
Denosumab is superior to alendronate for improving cortical bone porosity post-menopause
Bone. 2014 Feb;59:173-9. doi: 10.1016/j.bone.2013.11.016. Epub 2013 Nov 22.
Etidronate, alendronate, and reisendronate significantly reduce the risk of hip fracture
Curr Med Res Opin. 2011 Jun;27(6):1141-8. doi: 10.1185/03007995.2011.570747. Epub 2011 Apr 1
Adherence to weekly oral BP therapy versus quarterly IV BP therapy at varying health literacy level
J Bone Miner Metab. 2018 Sep;36(5):589-595. doi: 10.1007/s00774-017-0867-y
The effect of eldecalcitol on balence and strength in women with osteoporosis
J Bone Miner Metab. 2016 Sep;34(5):547-54
Improved bone mineral density up to 12 months with a 6-month oral alendronate intervention
J Bone Joint Surg Am. 2006 Feb;88(2):267-72
Teriparatide increases BMD in patients with glucocorticoid-Induced osteoporosis
N Engl J Med. 2007 Nov 15;357(20):2028-39